Zepbound (tirzepatide) : A dual GIP/GLP-1 agonist offering enhanced weight loss results
In just 84 days, Ive successfully lost weight, and my blood sugar is back to normal
Its anti-fibrotic action makes it particularly well-studied in models of chronic injury, cardiac fibrosis, and musculoskeletal lesions (Malinda et al., J Invest Dermatol 1999)
Average results varied by dose and time frame: Participants taking a 4 mg dose lost 47.2 pounds (lb), or about 19 percent of their starting body weight
I notice that tirzepatide concentrations can vary by pharmacy or brand
Historically, most peptides have been considered ineffective when swallowed because digestive enzymes in the stomach and small intestine break down protein structures before they can be absorbed